Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
Yifei Tan(Sichuan University), David M. Lubman(University of Michigan–Ann Arbor), Alva Cano(The University of Texas Southwestern Medical Center), Cristian D. Gutierrez Reyes(Texas Tech University), Yehia Mechref(Texas Tech University), Neehar D. Parikh(University of Michigan), Sara Verschleisser(The University of Texas Southwestern Medical Center), Zhijing Tan(University of Michigan), Zuowei Wu(Iowa State University), Jie Zhang(Shandong First Medical University), Amit G. Singal(The University of Texas Southwestern Medical Center), Yu Lin(Southern Medical University), Jianhui Zhu(University of Pittsburgh)
Cited by 12
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study
|Glycobiology|2007|396
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
|Nature Chemistry|2015|305
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177